Pathological Role of IL-6 in the Experimental Allergic Bronchial Asthma in Mice
Authors:
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 28 (3) , 257-270
Abstract
Although allergic asthma was described to be associated with the presence of mucosal T-helper (Th)2 cells, it is not entirely clear which factors are responsible for priming of T cells to differentiate into Th2 effector cells in this disease. Interleukin (IL)-6 has been recognized as important because it is secreted by cells of the innate immunity and induces the expansion of the Th2 effector cells, which are major players of the adaptive immune responses. Additionally, IL-6 released by dendritic cells (DCs) inhibits the suppressive function of CD4+CD25+ T-regulatory cells, thus inhibiting the peripheral tolerance. The signal transduction of IL-6 has recently taught us how this cytokine influences different aspects of the immune response, especially under pathological conditions. IL-6 can bind to the soluble IL-6R, increased after allergen challenge in asthmatic patients, and, through a mechanism called trans-signaling, induces proliferation of cells expressing the cognate receptor gp130. This mechanism appears to be used for proliferation by developed Th2 cells in the airways. In contrast, through the membrane-bound IL-6R, IL-6 controls CD4+CD25+ survival, as well as the initial stages of the Th2 cells development in the lung. These findings impact the establishment of new therapies for allergic diseases; indeed, blockade of the soluble IL-6R through the fusion protein gp130Fc reduces Th2 cells in the lung, and by blocking the membrane-bound Il-6R, anti-IL-6R antibody treatment induces the number of T-regulatory cells in the lung, thereby reducing the local number of CD4+ T-effector cells in experimental asthma.Keywords
This publication has 80 references indexed in Scilit:
- Potential role of interleukin-10-secreting regulatory T cells in allergy and asthmaNature Reviews Immunology, 2005
- Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6‐deficient mice following chronic exposure to aerosolized antigenClinical & Experimental Allergy, 2004
- Matching SOCS with functionNature Immunology, 2003
- IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESSAnnual Review of Immunology, 1999
- Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes.Journal of Clinical Investigation, 1997
- IL‐13 production by allergen‐stimulated T cells is increased in allergic disease and associated with IL‐5 but not IFN‐γ expressionImmunology, 1997
- Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte RecruitmentImmunity, 1997
- Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction.Journal of Clinical Investigation, 1996
- Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity.Journal of Clinical Investigation, 1994
- Human TH1 and TH2 subsets: doubt no moreImmunology Today, 1991